Reducing effect of nadolol on serum levels of free thyroid hormones in hyperthyroidism. 1994

T Kashiwai, and H Tada, and H Tamaki, and Y Hidaka, and E Ito, and Y Iwatani, and N Amino
Department of Laboratory Medicine, Osaka University Medical School, Japan.

We evaluated the effect of the beta-adrenergic receptor blocking agent nadolol on serum levels of free thyroid hormones in 20 untreated patients with Graves' disease, aged between 17 and 57 years (mean +/- SD, 32.9 +/- 10.5). All the patients were treated with 30 mg of nadolol alone once-daily for 2 weeks, and clinical and laboratory parameters before and after the treatment were compared. Systolic blood pressure was depressed significantly (P < 0.001) from 132.7 +/- 11.1 mmHg to 122.8 +/- 10.9 mmHg. The resting pulse rate was also reduced significantly (from 110.3 +/- 9.2/min to 86.0 +/- 13.2/min, P < 0.001). Serum free thyroxine levels were reduced significantly from 7.1 +/- 3.1 ng/dl to 5.7 +/- 3.6 ng/dl (P < 0.05) and serum free triiodothyronine levels were reduced from 21.9 +/- 5.6 pg/ml to 17.2 +/- 6.9 pg/ml (P < 0.01). In the present study, the beta-adrenergic receptor blocking agent nadolol was newly found to have a reducing effect on serum free thyroxine, as well as free triiodothyronine concentrations.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009248 Nadolol A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for MIGRAINE DISORDERS and for tremor. Corgard,SQ-11725,Solgol,SQ 11725,SQ11725
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013974 Thyroxine The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. L-Thyroxine,Levothyroxine,T4 Thyroid Hormone,3,5,3',5'-Tetraiodothyronine,Berlthyrox,Dexnon,Eferox,Eltroxin,Eltroxine,Euthyrox,Eutirox,L-3,5,3',5'-Tetraiodothyronine,L-Thyrox,L-Thyroxin Henning,L-Thyroxin beta,L-Thyroxine Roche,Levo-T,Levothroid,Levothyroid,Levothyroxin Deladande,Levothyroxin Delalande,Levothyroxine Sodium,Levoxine,Levoxyl,Lévothyrox,Novothyral,Novothyrox,O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine,O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine,Oroxine,Sodium Levothyroxine,Synthroid,Synthrox,Thevier,Thyrax,Thyroxin,Tiroidine,Tiroxina Leo,Unithroid,L Thyrox,L Thyroxin Henning,L Thyroxin beta,L Thyroxine,L Thyroxine Roche,Levo T,Thyroid Hormone, T4

Related Publications

T Kashiwai, and H Tada, and H Tamaki, and Y Hidaka, and E Ito, and Y Iwatani, and N Amino
April 1978, Australian and New Zealand journal of medicine,
T Kashiwai, and H Tada, and H Tamaki, and Y Hidaka, and E Ito, and Y Iwatani, and N Amino
March 1990, Kardiologiia,
T Kashiwai, and H Tada, and H Tamaki, and Y Hidaka, and E Ito, and Y Iwatani, and N Amino
January 1989, Endokrynologia Polska,
T Kashiwai, and H Tada, and H Tamaki, and Y Hidaka, and E Ito, and Y Iwatani, and N Amino
June 1989, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
T Kashiwai, and H Tada, and H Tamaki, and Y Hidaka, and E Ito, and Y Iwatani, and N Amino
February 1993, International journal of cardiology,
T Kashiwai, and H Tada, and H Tamaki, and Y Hidaka, and E Ito, and Y Iwatani, and N Amino
January 1981, Current medical research and opinion,
T Kashiwai, and H Tada, and H Tamaki, and Y Hidaka, and E Ito, and Y Iwatani, and N Amino
October 1998, European journal of endocrinology,
T Kashiwai, and H Tada, and H Tamaki, and Y Hidaka, and E Ito, and Y Iwatani, and N Amino
May 1959, The Journal of clinical endocrinology and metabolism,
T Kashiwai, and H Tada, and H Tamaki, and Y Hidaka, and E Ito, and Y Iwatani, and N Amino
July 1979, Archives of internal medicine,
T Kashiwai, and H Tada, and H Tamaki, and Y Hidaka, and E Ito, and Y Iwatani, and N Amino
August 1986, Journal of endocrinological investigation,
Copied contents to your clipboard!